Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Puretech Health Plc LSE:PRTC London Ordinary Share GB00BY2Z0H74 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.8% 247.00 247.00 248.00 251.00 246.00 250.00 27,017 12:45:52
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 12.9 -43.6 -15.5 - 711

Puretech Health Share Discussion Threads

Showing 1526 to 1547 of 1550 messages
Chat Pages: 62  61  60  59  58  57  56  55  54  53  52  51  Older
DateSubjectAuthorDiscuss
31/1/2023
10:10
Anyone know how much of the buyback they have used to date?
lendmeafiver
30/1/2023
11:27
Random isn’t it
lendmeafiver
25/1/2023
08:59
It appears to be back
edwardt
17/1/2023
15:38
Are they still doing a buyback?
lendmeafiver
06/1/2023
08:29
following the great news from akili, i thought i would add the size of the tam.
the global attention deficit hyperactivity disorder market size was valued at USD 13.21 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030.

15% of that market will do us nicely!

edwardt
12/12/2022
16:05
Agree, PRTC should be a lot higher.
rogers49
12/12/2022
15:47
nice rns. the venclexta drug referenced as a comparable has annual sales of $505m with abbvie. lets eat into that pie.
edwardt
09/12/2022
23:02
Agree, I've always had high hopes for their tech.

https://uk.advfn.com/stock-market/london/puretech-health-PRTC/share-news/PureTech-Health-PLC-Sonde-Gets-19M-for-Voice-Bas/89746131

rambutan2
09/12/2022
17:56
Decent raise for sonde - glad we followed our money there
edwardt
07/12/2022
18:48
Vor roars!
edwardt
02/12/2022
20:27
Just spotted this, which I guess has helped sentiment:

30/11/22 Today, the U.S. Food and Drug Administration approved Rebyota, the first fecal microbiota product approved by the agency. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older.

hTTps://www.fda.gov/news-events/press-announcements/fda-approves-first-fecal-microbiota-product

rambutan2
28/11/2022
09:53
Not sure but looks like we are heading for £3
af004
21/11/2022
13:58
anyone know why this has perked up today?
edwardt
11/10/2022
13:29
Has raised doubts about Daphne and co's competence and intentions and the quality of the portfolio I would have thought. Had they not read up on UK takeover framework, or thought about how the mkt might view the deal etc etc. All a bit Trussian. Now they are going to have to earn back the mkt's confidence. imho
rambutan2
11/10/2022
07:15
So PRTC sees a large drop on offer talks. You would assume once offer talks were off the price rebounds?
liam1om
11/10/2022
07:14
yes and predicted.
babbler
11/10/2022
07:05
i think that is probably for the best!
edwardt
10/10/2022
13:30
So, all is unclear as to what exactly is going on!

hTTps://www.fiercebiotech.com/biotech/puretech-confirms-nektar-merger-rumors-potential-lifeline-former-bms-partner

rambutan2
10/10/2022
13:26
Hmmm:

"Mizuho analysts suggest a more prosaic reason for tying the companies up: Puretech’s president is Bharat Chowiria, and he had once served as chairman and chief business officer of Nektar. Still, back then Nektar was focusing on inhaled insulin, and had yet to turn to oncology, the strategy that yielded bempegaldesleukin."

hTtps://www.evaluate.com/vantage/articles/news/deals/nektar-and-puretech-make-strange-bedfellows

rambutan2
10/10/2022
13:18
Trying to get my head round what going on:

"The clinical setback knocked $1 billion off of Nektar’s market capitalization, and at Thursday’s $3.38-a-share close the company valuation was $633 million, slightly above its $619 million in cash holdings as of June 30."

htTps://www.biopharmadive.com/news/nektar-puretech-acquisition-talks/633594/

rambutan2
07/10/2022
15:23
i note invesco are biggest shareholders of both. but yes - reaction probably a bit harsh as they have not agreed to anything.
edwardt
07/10/2022
15:19
tbf it's a proposal to them. They had to let shareholders know. They likely will reject it. Then can move back up.
babbler
Chat Pages: 62  61  60  59  58  57  56  55  54  53  52  51  Older
Your Recent History
LSE
PRTC
Puretech H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230208 13:03:33